(Q44436562)

3 December 2017

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

1

1 reference

3 December 2017

8

Pierre Sokoloff

1 reference

3 December 2017

Sandrine Ferry

2

1 reference

3 December 2017

Ulrich Mach

3

1 reference

3 December 2017

Holger Stark

4

1 reference

3 December 2017

Ludovic Leriche

5

1 reference

3 December 2017

Thomas Boraud

6

1 reference

3 December 2017

Christian Gross

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

12 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

9

1 reference

3 December 2017

762-767

1 reference

3 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nm875

3 December 2017

0 references

cites work

A paradigm shift in brain research

1 reference

Being partial to psychostimulant addiction therapy

21 January 2018

1 reference

Pharmacology of dopamine agonists in the treatment of Parkinson's disease

21 January 2018

1 reference

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

21 January 2018

1 reference

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

21 January 2018

1 reference

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 January 2018

1 reference

Modification of Parkinsonism--chronic treatment with L-dopa

21 January 2018

1 reference

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

21 January 2018

1 reference

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.

21 January 2018

1 reference

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.

21 January 2018

1 reference

D3 receptor expression within the basal ganglia is not affected by Parkinson's disease

21 January 2018

1 reference

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys

21 January 2018

1 reference

Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line

21 January 2018

1 reference

D3 dopamine receptor mRNA is widely expressed in the human brain

21 January 2018

1 reference

Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

21 January 2018

1 reference

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

21 January 2018

1 reference

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

21 January 2018

1 reference

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

21 January 2018

1 reference

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

21 January 2018

1 reference

Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists

21 January 2018

1 reference

Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment

21 January 2018

1 reference

7 January 2021

In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT

1 reference

7 January 2021

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

1 reference

7 January 2021

Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey

1 reference

7 January 2021

Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM875

1 reference

3 December 2017

1 reference